InsidersTradesSigma
Follow the SNT stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on AU AU, under the authority of ASX. Operating in the Health Care sector, SNT has published 1 reports. Market capitalisation: €2.5bn. The latest transaction was reported on 11 May 2026 (Change in Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is free.
Analysts rate SNT Strong Buy (bullish), based on 5 analysts. Average price target: PLN 315.46.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.